InvestorsHub Logo
Followers 6
Posts 1011
Boards Moderated 0
Alias Born 04/11/2013

Re: kaylawa post# 16594

Saturday, 10/12/2013 2:21:51 PM

Saturday, October 12, 2013 2:21:51 PM

Post# of 425239
kay - Hiatts pubs https://profiles.ucdenver.edu/display/224140

#1 & 3 look interesting, have not been able to open yet

Found he co-authored a paper with GSK person but I lost track of it since yesterday


http://www.foxnews.com/health/2013/06/07/fda-panel-votes-to-relax-avandia-restrictions/
FDA panel votes to relax Avandia (GSK) restrictions

Avandia was once the world's best-selling treatment for type 2 diabetes, with annual sales of $3.2 billion.

"In general, this drug doesn't look any different than any other diabetes drug," said Dr. William Hiatt, a cardiologist from the University of Colorado, who was among seven experts who backed lifting restrictions altogether.

In 2010 its use in the United States was heavily restricted and it was withdrawn from the market in Europe because of the possibility of increased risk of heart attack and stroke. Only 3,000 people in the United States take it today, down from about 120,000 just before the restrictions were put in place.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News